| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Steve Orme, Richard McNally, Peter W James, Jessica Davis, John Ayuk, Claire Higham, John Was. Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels-A retrospective analysis from the UK Acromegaly Register 1970-2016. Clinical endocrinology. 2024-04-23. PMID:38652736. |
increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of gh levels-a retrospective analysis from the uk acromegaly register 1970-2016. |
2024-04-23 |
2024-04-26 |
Not clear |
| Steve Orme, Richard McNally, Peter W James, Jessica Davis, John Ayuk, Claire Higham, John Was. Increased mortality in acromegaly is due to vascular and respiratory disease and is normalised by control of GH levels-A retrospective analysis from the UK Acromegaly Register 1970-2016. Clinical endocrinology. 2024-04-23. PMID:38652736. |
epidemiological studies involving patients with acromegaly have yielded conflicting results regarding cancer incidence and causes of mortality in relation to control of growth hormone (gh) excess. |
2024-04-23 |
2024-04-26 |
Not clear |
| Anke Tönjes, Marleen Würfel, Marcus Quinkler, Ulrich J Knappe, Jürgen Honegger, Nina Krause-Joppig, Konrad Bacher, Timo Deutschbein, Sylvère Störmann, Jochen Schopohl, Sebastian M Meyhöfe. Pregnancy and acromegaly: clinical outcomes of retrospectively analysed data from the German acromegaly registry. Reproductive biology and endocrinology : RB&E. vol 22. issue 1. 2024-04-22. PMID:38650041. |
acromegaly is a rare disease caused by excessive growth hormone (gh) secretion, mostly induced by pituitary adenomas. |
2024-04-22 |
2024-04-26 |
Not clear |
| Daniel Cuevas-Ramos, Shlomo Melme. Acromegaly Type 1: A Representative Patient. JCEM case reports. vol 2. issue 4. 2024-04-18. PMID:38633358. |
biochemical evaluation, including insulin-like growth factor type 1 (igf-1) measurement and oral glucose loading with growth hormone (gh) measurement confirmed excess gh production and a diagnosis of acromegaly. |
2024-04-18 |
2024-04-20 |
Not clear |
| Busra Firlatan, Ugur Nadir Karakulak, Vedat Hekimsoy, Burcin Gonul Iremli, Incilay Lay, Deniz Yuce, Selcuk Dagdelen, Giray Kabakci, Tomris Erba. Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly. Hormones (Athens, Greece). 2024-04-17. PMID:38632216. |
in patients with acromegaly, the long-term presence of elevated gh and igf-1 levels is associated with an unfavorable cardiovascular risk profile. |
2024-04-17 |
2024-04-20 |
Not clear |
| Federica Guaraldi, Francesca Ambrosi, Costantino Ricci, Luisa Di Sciascio, Sofia Asiol. Histopathology of growth hormone-secreting pituitary tumors: State of the art and new perspectives. Best practice & research. Clinical endocrinology & metabolism. 2024-04-13. PMID:38614953. |
somatotroph (gh) adenomas/pitnets typically arise from adenohypophysis and are biochemically active, leading to acromegaly and gigantism. |
2024-04-13 |
2024-04-16 |
Not clear |
| Kohei Oguni, Koichiro Yamamoto, Yasuhiro Nakano, Yoshiaki Soejima, Atsuhito Suyama, Ryosuke Takase, Miho Yasuda, Kou Hasegawa, Fumio Otsuk. Trends of correlations between serum levels of growth hormone and insulin-like growth factor-I in general practice. Frontiers in endocrinology. vol 15. 2024-04-10. PMID:38596224. |
of 642 patients, 33 patients were diagnosed with acromegaly, 21 were diagnosed with gh deficiency (ghd), and 588 were diagnosed with non-gh-related diseases (ngrd). |
2024-04-10 |
2024-04-12 |
Not clear |
| Kohei Oguni, Koichiro Yamamoto, Yasuhiro Nakano, Yoshiaki Soejima, Atsuhito Suyama, Ryosuke Takase, Miho Yasuda, Kou Hasegawa, Fumio Otsuk. Trends of correlations between serum levels of growth hormone and insulin-like growth factor-I in general practice. Frontiers in endocrinology. vol 15. 2024-04-10. PMID:38596224. |
in contrast to the positive correlations found between the levels of gh and igf-i in patients with acromegaly ( |
2024-04-10 |
2024-04-12 |
Not clear |
| Giuseppe Grande, Andrea Graziani, Luca DE Toni, Alberto Ferli. Proteomics for the identification of peripheral markers in pituitary disease. Minerva endocrinology. 2024-04-09. PMID:38591851. |
in this narrative mini-review, the role of proteomics is discussed with a particular focus on the few attempts of the application of proteomic platforms for the identification of new biomarkers in pituitary diseases, namely in acromegaly, gh deficiency and male secondary hypogonadism. |
2024-04-09 |
2024-04-11 |
Not clear |
| Maryam Thaer Saadi, Noor Ulhuda G Mohammed, Baydaa Ahmed Abed, Layla Othman Farhan, Isam Noori Salma. Validity of galactin-3 in acromegaly: comparison with traditional markers. Irish journal of medical science. 2024-03-23. PMID:38520613. |
acromegaly occurs due to overproduction of growth hormone (gh) and insulin-like growth factor-1 (igf-1). |
2024-03-23 |
2024-03-26 |
Not clear |
| Lucio Vilar, Luciana Ansaneli Naves, Manoel Ricardo Alves Martins, Antônio Ribeiro-Oliveir. "Micromegaly": Acromegaly with apparently normal GH, an entity on its own? Best practice & research. Clinical endocrinology & metabolism. 2024-03-22. PMID:38519400. |
"micromegaly": acromegaly with apparently normal gh, an entity on its own? |
2024-03-22 |
2024-03-25 |
Not clear |
| Lucio Vilar, Luciana Ansaneli Naves, Manoel Ricardo Alves Martins, Antônio Ribeiro-Oliveir. "Micromegaly": Acromegaly with apparently normal GH, an entity on its own? Best practice & research. Clinical endocrinology & metabolism. 2024-03-22. PMID:38519400. |
a small proportion of the patients with acromegaly present with apparently normal basal gh levels and suppressible gh levels despite increased igf-1 levels, a pattern called micromegaly by some authors. |
2024-03-22 |
2024-03-25 |
Not clear |
| Tomoyuki Hata, Yoshikatsu Uematsu, Ayumi Sugita, Hisashi Adachi, Sayaka Kato, Maki Hirate, Kei-Ichiro Ishikura, Ayaka Kaku, Hiroki Ohara, Naoki Kojima, Teisuke Takahashi, Tomofumi Kurokaw. A Potent Neutralizing Monoclonal Antibody to Human Growth Hormone Suppresses Insulin-Like Growth Factor-1 in female Rats. Endocrinology. 2024-03-19. PMID:38500360. |
acromegaly and gigantism are disorders caused by hypersecretion of growth hormone (gh), usually from pituitary adenomas. |
2024-03-19 |
2024-03-21 |
mouse |
| Ahmed Anass Guerboub, Jad Issouani, Kesly Jeny Joumas, Yassine Er Rahal. Acromegaly among a Moroccan population. The Pan African medical journal. vol 46. 2024-03-11. PMID:38465009. |
acromegaly is defined as an acquired dysmorphytic syndrome due to excessive secretion of growth hormone (gh) and consequently of insulin-like growth factor-1 (igf-1). |
2024-03-11 |
2024-03-14 |
Not clear |
| E O Mamedova, E G Przhiyalkovskaya, S A Buryakina, E V Bondarenko, A M Lapshina, M Yu Pikunov, Zh E Belaya, G A Melnichenk. [Ectopic acromegaly due to bronchial neuroendocrine tumors: the first description in Russia of three clinical cases]. Problemy endokrinologii. vol 70. issue 1. 2024-03-04. PMID:38433543. |
in the majority of cases the cause of acromegaly is a pituitary tumor producing gh. |
2024-03-04 |
2024-03-06 |
Not clear |
| E O Mamedova, E G Przhiyalkovskaya, S A Buryakina, E V Bondarenko, A M Lapshina, M Yu Pikunov, Zh E Belaya, G A Melnichenk. [Ectopic acromegaly due to bronchial neuroendocrine tumors: the first description in Russia of three clinical cases]. Problemy endokrinologii. vol 70. issue 1. 2024-03-04. PMID:38433543. |
ectopic acromegaly occurs in cases of tumors which produce growth hormone-releasing hormone (ghrh) or extrapituitary tumors which produce gh. |
2024-03-04 |
2024-03-06 |
Not clear |
| Angelo Milioto, Giuliana Corica, Federica Nista, Luiz Eduardo Armondi Wildemberg, Federica Rossi, Bianca Bignotti, Mônica R Gadelha, Diego Ferone, Alberto Stefano Tagliafico, Federico Gatt. Skeletal Muscle Evaluation in Patients With Acromegaly. Journal of the Endocrine Society. vol 8. issue 4. 2024-03-04. PMID:38434516. |
patients with acromegaly are characterized by chronic exposure to high growth hormone (gh) and insulin-like growth factor-1 levels, known for their anabolic effect on skeletal muscle. |
2024-03-04 |
2024-03-06 |
Not clear |
| Patricia Fainstein-Day, Tamara Estefanía Ullmann, Mercedes Corina Liliana Dalurzo, Gustavo Emilio Sevlever, David Eduardo Smit. The clinical and biochemical spectrum of ectopic acromegaly. Best practice & research. Clinical endocrinology & metabolism. 2024-02-27. PMID:38413286. |
ectopic acromegaly is a rare condition caused by extrapituitary central or peripheral neuroendocrine tumours (net) that hypersecrete gh or, more commonly, ghrh. |
2024-02-27 |
2024-03-01 |
Not clear |
| Anna Bogusławska, Magdalena Godlewska, Alicja Hubalewska-Dydejczyk, Márta Korbonits, Jerzy Starzyk, Aleksandra Gilis-Januszewsk. Tall stature and gigantism in adult patients with acromegaly. European journal of endocrinology. 2024-02-23. PMID:38391173. |
increased height in patients with acromegaly could be a manifestation of growth hormone (gh) excess before epiphysis closure. |
2024-02-23 |
2024-02-25 |
Not clear |
| Anna Bogusławska, Magdalena Godlewska, Alicja Hubalewska-Dydejczyk, Márta Korbonits, Jerzy Starzyk, Aleksandra Gilis-Januszewsk. Tall stature and gigantism in adult patients with acromegaly. European journal of endocrinology. 2024-02-23. PMID:38391173. |
the aim of this study was to evaluate the relationship between the height of adult patients with gh excess related to mid-parental height (mph) and population mean and to find whether taller patients with acromegaly come from tall families. |
2024-02-23 |
2024-02-25 |
Not clear |